HAMILL JOHN P. (SrVP/CFO/Prin Fin & Acct Ofcr) purchased 20.6% of their position (5.70K shares) of APREA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/2/2026ACC: 0001104659-26-009203
Officer· SrVP/CFO/Prin Fin & Acct Ofcr
Since Jan 2026
+11.40K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
11.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.70K
Price / share
$0.89
Trade value
$5.07K
% of position
20.6%
1/30/2026
27.73K→33.43K
Total
Net shares
+5.70K
Net value
$5.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | P · Purchase | +5.70K | $0.89 | $5.07K | 20.6% | 27.73K | 33.43K |
| Total | +5.70K | $5.07K | ||||||
Derivative Transactions1
Common Warrant
Direct
Converts to
Common Stock
5.70K shares
Shares
+5.70K
Strike price
0.765
Held after
5.70K
Exercisable
—
1/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrant Direct | Common Stock5.70K shares | 1/30/2026 | P · Purchase | +5.70K | 0.765 | — | 5.70K |